ALBERTI, MARTINA
ALBERTI, MARTINA
DMED - DIPARTIMENTO DI MEDICINA
Mostra
records
Risultati 1 - 4 di 4 (tempo di esecuzione: 0.008 secondi).
Adjuvant durvalumab after concurrent chemoradiotherapy for patients with unresectable stage III NSCLC harbouring uncommon genomic alterations
2023-01-01 Cortiula, F.; De Ruysscher, D.; Steens, M.; Wijsman, R.; van der Wekken, A.; Alberti, M.; Hendriks, L. E. L.
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer
2022-01-01 Roncato, R.; Gerratana, L.; Palmero, L.; Gagno, S.; Poetto, A. S.; Peruzzi, E.; Zanchetta, M.; Posocco, B.; De Mattia, E.; Canil, G.; Alberti, M.; Orleni, M.; Toffoli, G.; Puglisi, F.; Cecchin, E.
Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects
2022-01-01 Di Nardo, P.; Lisanti, C.; Garutti, M.; Buriolla, S.; Alberti, M.; Mazzeo, R.; Puglisi, F.
“A new LC-MS/MS method for the simultaneous quantification of abemaciclib, its main active metabolites M2 and M20, and letrozole for therapeutic drug monitoring”
2022-01-01 Soledad Poetto, A.; Posocco, B.; Zanchetta, M.; Gagno, S.; Orleni, M.; Canil, G.; Alberti, M.; Puglisi, F.; Toffoli, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Adjuvant durvalumab after concurrent chemoradiotherapy for patients with unresectable stage III NSCLC harbouring uncommon genomic alterations | 1-gen-2023 | Cortiula, F.; De Ruysscher, D.; Steens, M.; Wijsman, R.; van der Wekken, A.; Alberti, M.; Hendriks, L. E. L. | |
| An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer | 1-gen-2022 | Roncato, R.; Gerratana, L.; Palmero, L.; Gagno, S.; Poetto, A. S.; Peruzzi, E.; Zanchetta, M.; Posocco, B.; De Mattia, E.; Canil, G.; Alberti, M.; Orleni, M.; Toffoli, G.; Puglisi, F.; Cecchin, E. | |
| Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects | 1-gen-2022 | Di Nardo, P.; Lisanti, C.; Garutti, M.; Buriolla, S.; Alberti, M.; Mazzeo, R.; Puglisi, F. | |
| “A new LC-MS/MS method for the simultaneous quantification of abemaciclib, its main active metabolites M2 and M20, and letrozole for therapeutic drug monitoring” | 1-gen-2022 | Soledad Poetto, A.; Posocco, B.; Zanchetta, M.; Gagno, S.; Orleni, M.; Canil, G.; Alberti, M.; Puglisi, F.; Toffoli, G |